IRS Issues PLR Holding a Portion of DNA Test Kit Represents Deductible Medical Expense
The Wall Street Journal reported that genetic testing service 23andMe has received a private letter ruling from the IRS that allows a portion of the payment made to the entity to be treated as a medical expense.[1] A redacted copy of the ruling has been posted by the company on its website.[2] The Wall Street Journal article noted that the IRS will publish the standard redacted PLR in August.[3]
Read More